These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36943124)

  • 1. [Towards understanding chronic kidney disease].
    Vergnaud P; Cohen C; Isnard P
    Med Sci (Paris); 2023 Mar; 39(3):265-270. PubMed ID: 36943124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing Protein Permeability with Nephron Loss: Evidence for a Human Remnant Nephron Effect.
    Willows J; Odudu A; Logan I; Sheerin N; Tomson C; Ellam T
    Am J Nephrol; 2019; 50(2):152-159. PubMed ID: 31269482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function.
    Denic A; Elsherbiny H; Mullan AF; Leibovich BC; Thompson RH; Ricaurte Archila L; Narasimhan R; Kremers WK; Alexander MP; Lieske JC; Lerman LO; Rule AD
    J Am Soc Nephrol; 2020 Nov; 31(11):2642-2652. PubMed ID: 32938650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways to nephron loss starting from glomerular diseases-insights from animal models.
    Kriz W; LeHir M
    Kidney Int; 2005 Feb; 67(2):404-19. PubMed ID: 15673288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection.
    Haruhara K; Kanzaki G; Tsuboi N
    Hypertens Res; 2023 Feb; 46(2):299-310. PubMed ID: 36224286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephron overload as a therapeutic target to maximize kidney lifespan.
    Luyckx VA; Rule AD; Tuttle KR; Delanaye P; Liapis H; Gandjour A; Romagnani P; Anders HJ
    Nat Rev Nephrol; 2022 Mar; 18(3):171-183. PubMed ID: 34880459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights on glomerular hyperfiltration: a Japanese autopsy study.
    Kanzaki G; Puelles VG; Cullen-McEwen LA; Hoy WE; Okabayashi Y; Tsuboi N; Shimizu A; Denton KM; Hughson MD; Yokoo T; Bertram JF
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5/6th nephrectomy in combination with high salt diet and nitric oxide synthase inhibition to induce chronic kidney disease in the Lewis rat.
    van Koppen A; Verhaar MC; Bongartz LG; Joles JA
    J Vis Exp; 2013 Jul; (77):e50398. PubMed ID: 23851420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'-implications for pre-clinical research and drug testing.
    Anguiano Gómez L; Lei Y; Kumar Devarapu S; Anders HJ
    Nephrol Dial Transplant; 2018 Aug; 33(8):1292-1304. PubMed ID: 28992221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Renal Pathology of Obesity: Structure-Function Correlations.
    Tsuboi N; Okabayashi Y
    Semin Nephrol; 2021 Jul; 41(4):296-306. PubMed ID: 34715960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephron Deficiency and Predisposition to Renal Injury in a Novel One-Kidney Genetic Model.
    Wang X; Johnson AC; Williams JM; White T; Chade AR; Zhang J; Liu R; Roman RJ; Lee JW; Kyle PB; Solberg-Woods L; Garrett MR
    J Am Soc Nephrol; 2015 Jul; 26(7):1634-46. PubMed ID: 25349207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular hyperfiltration as a therapeutic target for CKD.
    Kanbay M; Copur S; Bakir CN; Covic A; Ortiz A; Tuttle KR
    Nephrol Dial Transplant; 2024 Jul; 39(8):1228-1238. PubMed ID: 38308513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging-Related Kidney Diseases.
    Kitai Y; Nangaku M; Yanagita M
    Contrib Nephrol; 2021; 199():266-273. PubMed ID: 34343996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Normal and pathological renal aging in animals].
    Corman B
    Presse Med; 1992 Jul; 21(26):1238-45. PubMed ID: 1409479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional adaptation to reduction in renal mass.
    Hayslett JP
    Physiol Rev; 1979 Jan; 59(1):137-64. PubMed ID: 220646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Nephron Number and Single-Nephron Parameters in Patients with IgA Nephropathy.
    Marumoto H; Tsuboi N; D'Agati VD; Sasaki T; Okabayashi Y; Haruhara K; Kanzaki G; Koike K; Shimizu A; Kawamura T; Rule AD; Bertram JF; Yokoo T
    Kidney360; 2021 May; 2(5):828-841. PubMed ID: 35373063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.
    Chapron A; Shen DD; Kestenbaum BR; Robinson-Cohen C; Himmelfarb J; Yeung CK
    Clin Transl Sci; 2017 Sep; 10(5):395-403. PubMed ID: 28675584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.